温肾化瘀散结法治疗慢性肾病继发性甲旁亢的临床研究

来源 :浙江省生物医学工程学会肾脏病透析移植分会2015年学术年会 | 被引量 : 0次 | 上传用户:bainiao528
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  目的:观察温肾化瘀散结法治疗慢性肾病继发性甲旁亢的临床疗效.方法:将40例患者作为研究对象随机分为对照组和治疗组,对照组给予西药骨化三醇胶丸治疗,治疗组采用温肾化瘀散结法结合骨化三醇胶丸治疗.结果:1.治疗组有效率、iPTH水平降低方面均优于对照组(P<0.05),2.治疗组在改善骨痛、皮肤瘙痒症状,改善肾小球滤过率、降低钙磷乘积、碱性磷酸酶方面均优于对照组(P<0.05).结论:温肾化瘀散结法结合骨化三醇胶丸治疗慢性肾病继发性甲旁亢,可以提高临床治疗效果,值得进一步研究和推广应用.
其他文献
Objective: Erectile dysfunction(ED)is one of the most common complications of diabetes mellitus(DM).Under the background that effectivity of treatments for diabetic ED are quite poor,stem cell therapy
Objective: Erectile dysfunction(ED)following radical prostatectomy(RP)can occur as a result of cavernous nerve(CN)injury.Even with the surgical progress of CN preservation techniques and/or introducti
Objective: To explore the effects of transplantation of bone marrow-derived mesenchymal stem cells(BM-MSCs)on improving erectile function of streptozocin(STZ)-induced diabetic rats.Methods: Male Sprag
Objective: Prognostic epigenetic biomarkers and clinical factors in upper tract urothelial carcinoma(UTUC)are inconclusive.We conducted this study to identify gene promoter(ABCC6,BRCA1,CDH1,GDF15,HSPA
Objective: To recognize a novel and optimized combination of epigenetic biomarkers capable of returning higher sensitivity and specificity synergistically in pathologically varied sample groups for ur
Objective: Isolated gonadotropin-releasing hormone(GnRH)deficiency(IGD)is a rare clinical condition with a broad spectrum of human reproductive disorders which varies from congenital isolated hypogona
Objective: Mental health disorders(MHD)in chronic prostatitis/chronic pelvic pain syndrome(CP/CPPS)have been widely studied.However,the underlying molecular mechanisms and,in particular,role of inflam
Objective:Mitochondrial damage and oxidative stress play critical roles in the pathogenesis of diabetic nephropathy (DN),especially during renal tubular injury.Our previous study (JASN,2015) has demon
会议
目的 观察雷公藤多甙治疗糖尿病肾病的临床疗效及副作用.方法 56例本院2001年1月-2014年12月住院的糖尿病肾病患者,肝肾功能、血常规正常,24小时尿蛋白定量均在29以上,随机分为治疗组和对照组.治疗组26例,对照组30例,两组均予胰岛素降血糖、血管紧张素转化酶抑制剂(ACEI)或血管紧张素Ⅱ受体阻滞剂(ARB)降压、降尿蛋白,辅以降脂及抗凝治疗,治疗组同时予雷公藤多甙片20mg每天三次,疗
会议
Background: Idiopathic membranous nephropathy(IMN)is a major cause of nephrotic syndrome among adults.Given the special nature course of IMN,when to treat and with which immunosuppressive treatment ne